Ironwood Pharma (IRWD) Tops Q3 EPS by 29c, Revenues Beat; Boosts FY19 Revenue Guidance Above Consensus
Tweet Send to a Friend
Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.40, $0.29 better than the analyst estimate of $0.11. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
